Document is current
Any future updates will be listed below
-
Authors
Perez-Saez, Javier https://orcid.org/0000-0003-3909-2048
Zheng, Qulu
Kaminsky, Joshua
Zou, Kaiyue https://orcid.org/0000-0002-2568-8193
Demby, Maya N. https://orcid.org/0000-0002-5315-325X
Alam, Christina
Landau, Daniel
DePencier, Rachel
Langa, Jose Paulo M.
Chilengi, Roma https://orcid.org/0000-0003-0221-9527
Welo Okitayemba, Placide
Bwire, Godfrey https://orcid.org/0000-0002-8376-2857
Esso, Linda
Ngomba, Armelle Viviane
Fouda Mbarga, Nicole https://orcid.org/0000-0002-0508-8027
Okunga, Emmanuel Wandera
Yennan, Sebastian
Kapaya, Fred
Ohize, Stephen Ogirima https://orcid.org/0000-0001-9206-1596
Seriki, Adive Joseph
Hegde, Sonia T. https://orcid.org/0000-0001-6426-0096
Sikder, Mustafa https://orcid.org/0000-0002-6977-7913
Lessler, Justin
Datta, Abhirup
Azman, Andrew S. https://orcid.org/0000-0001-8662-9077
Lee, Elizabeth C. https://orcid.org/0000-0002-4156-9637
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865, INV-044865)
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 18 June 2025
First Online: 7 August 2025
Competing interests
: Several authors participate regularly in meetings or are members of the Global Task Force on Cholera Control Surveillance and Oral Cholera Vaccine Working Groups, which provide technical expertise on cholera surveillance and oral cholera vaccine use. A.S.A. is a member of the Gavi Independent Review Committee.
